Infantile Spasms Therapeutics Industry Research Report 2024
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
According to APO Research, The global Infantile Spasms Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Infantile Spasms Therapeutics key players include Mallinckrodt, H. Lundbeck, etc. Global top two manufacturers hold a share over 60%.
In terms of product, Oral is the largest segment, with a share obout 55%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Infantile Spasms Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infantile Spasms Therapeutics.
The Infantile Spasms Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infantile Spasms Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Infantile Spasms Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Infantile Spasms Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Infantile Spasms Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Infantile Spasms Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Chapter 13: The main points and conclusions of the report.
According to APO Research, The global Infantile Spasms Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Infantile Spasms Therapeutics key players include Mallinckrodt, H. Lundbeck, etc. Global top two manufacturers hold a share over 60%.
In terms of product, Oral is the largest segment, with a share obout 55%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Infantile Spasms Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infantile Spasms Therapeutics.
The Infantile Spasms Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infantile Spasms Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Mallinckrodt
- H. Lundbeck
- Insys Therapeutics
- Orphelia Pharma
- Valerion Therapeutics
- Catalyst Pharmaceuticals
- Anavex Life Sciences
- Retrophin
- GW Pharmaceuticals
- Oral
- Injection
- Hospital
- Clinic
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Infantile Spasms Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Infantile Spasms Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Infantile Spasms Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Infantile Spasms Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Infantile Spasms Therapeutics by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Oral
2.2.3 Injection
2.3 Infantile Spasms Therapeutics by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Hospital
2.3.3 Clinic
2.3.4 Other
2.4 Assumptions and Limitations
3 INFANTILE SPASMS THERAPEUTICS BREAKDOWN DATA BY TYPE
3.1 Global Infantile Spasms Therapeutics Historic Market Size by Type (2019-2024)
3.2 Global Infantile Spasms Therapeutics Forecasted Market Size by Type (2025-2030)
4 INFANTILE SPASMS THERAPEUTICS BREAKDOWN DATA BY APPLICATION
4.1 Global Infantile Spasms Therapeutics Historic Market Size by Application (2019-2024)
4.2 Global Infantile Spasms Therapeutics Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Infantile Spasms Therapeutics Market Perspective (2019-2030)
5.2 Global Infantile Spasms Therapeutics Growth Trends by Region
5.2.1 Global Infantile Spasms Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Infantile Spasms Therapeutics Historic Market Size by Region (2019-2024)
5.2.3 Infantile Spasms Therapeutics Forecasted Market Size by Region (2025-2030)
5.3 Infantile Spasms Therapeutics Market Dynamics
5.3.1 Infantile Spasms Therapeutics Industry Trends
5.3.2 Infantile Spasms Therapeutics Market Drivers
5.3.3 Infantile Spasms Therapeutics Market Challenges
5.3.4 Infantile Spasms Therapeutics Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Infantile Spasms Therapeutics Players by Revenue
6.1.1 Global Top Infantile Spasms Therapeutics Players by Revenue (2019-2024)
6.1.2 Global Infantile Spasms Therapeutics Revenue Market Share by Players (2019-2024)
6.2 Global Infantile Spasms Therapeutics Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Infantile Spasms Therapeutics Head office and Area Served
6.4 Global Infantile Spasms Therapeutics Players, Product Type & Application
6.5 Global Infantile Spasms Therapeutics Players, Date of Enter into This Industry
6.6 Global Infantile Spasms Therapeutics Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Infantile Spasms Therapeutics Market Size (2019-2030)
7.2 North America Infantile Spasms Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Infantile Spasms Therapeutics Market Size by Country (2019-2024)
7.4 North America Infantile Spasms Therapeutics Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Infantile Spasms Therapeutics Market Size (2019-2030)
8.2 Europe Infantile Spasms Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Infantile Spasms Therapeutics Market Size by Country (2019-2024)
8.4 Europe Infantile Spasms Therapeutics Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Infantile Spasms Therapeutics Market Size (2019-2030)
9.2 Asia-Pacific Infantile Spasms Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Infantile Spasms Therapeutics Market Size by Country (2019-2024)
9.4 Asia-Pacific Infantile Spasms Therapeutics Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Infantile Spasms Therapeutics Market Size (2019-2030)
10.2 Latin America Infantile Spasms Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Infantile Spasms Therapeutics Market Size by Country (2019-2024)
10.4 Latin America Infantile Spasms Therapeutics Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Infantile Spasms Therapeutics Market Size (2019-2030)
11.2 Middle East & Africa Infantile Spasms Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Infantile Spasms Therapeutics Market Size by Country (2019-2024)
11.4 Middle East & Africa Infantile Spasms Therapeutics Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 Mallinckrodt
12.1.1 Mallinckrodt Company Information
12.1.2 Mallinckrodt Business Overview
12.1.3 Mallinckrodt Revenue in Infantile Spasms Therapeutics Business (2019-2024)
12.1.4 Mallinckrodt Infantile Spasms Therapeutics Product Portfolio
12.1.5 Mallinckrodt Recent Developments
12.2 H. Lundbeck
12.2.1 H. Lundbeck Company Information
12.2.2 H. Lundbeck Business Overview
12.2.3 H. Lundbeck Revenue in Infantile Spasms Therapeutics Business (2019-2024)
12.2.4 H. Lundbeck Infantile Spasms Therapeutics Product Portfolio
12.2.5 H. Lundbeck Recent Developments
12.3 Insys Therapeutics
12.3.1 Insys Therapeutics Company Information
12.3.2 Insys Therapeutics Business Overview
12.3.3 Insys Therapeutics Revenue in Infantile Spasms Therapeutics Business (2019-2024)
12.3.4 Insys Therapeutics Infantile Spasms Therapeutics Product Portfolio
12.3.5 Insys Therapeutics Recent Developments
12.4 Orphelia Pharma
12.4.1 Orphelia Pharma Company Information
12.4.2 Orphelia Pharma Business Overview
12.4.3 Orphelia Pharma Revenue in Infantile Spasms Therapeutics Business (2019-2024)
12.4.4 Orphelia Pharma Infantile Spasms Therapeutics Product Portfolio
12.4.5 Orphelia Pharma Recent Developments
12.5 Valerion Therapeutics
12.5.1 Valerion Therapeutics Company Information
12.5.2 Valerion Therapeutics Business Overview
12.5.3 Valerion Therapeutics Revenue in Infantile Spasms Therapeutics Business (2019-2024)
12.5.4 Valerion Therapeutics Infantile Spasms Therapeutics Product Portfolio
12.5.5 Valerion Therapeutics Recent Developments
12.6 Catalyst Pharmaceuticals
12.6.1 Catalyst Pharmaceuticals Company Information
12.6.2 Catalyst Pharmaceuticals Business Overview
12.6.3 Catalyst Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2019-2024)
12.6.4 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Product Portfolio
12.6.5 Catalyst Pharmaceuticals Recent Developments
12.7 Anavex Life Sciences
12.7.1 Anavex Life Sciences Company Information
12.7.2 Anavex Life Sciences Business Overview
12.7.3 Anavex Life Sciences Revenue in Infantile Spasms Therapeutics Business (2019-2024)
12.7.4 Anavex Life Sciences Infantile Spasms Therapeutics Product Portfolio
12.7.5 Anavex Life Sciences Recent Developments
12.8 Retrophin
12.8.1 Retrophin Company Information
12.8.2 Retrophin Business Overview
12.8.3 Retrophin Revenue in Infantile Spasms Therapeutics Business (2019-2024)
12.8.4 Retrophin Infantile Spasms Therapeutics Product Portfolio
12.8.5 Retrophin Recent Developments
12.9 GW Pharmaceuticals
12.9.1 GW Pharmaceuticals Company Information
12.9.2 GW Pharmaceuticals Business Overview
12.9.3 GW Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2019-2024)
12.9.4 GW Pharmaceuticals Infantile Spasms Therapeutics Product Portfolio
12.9.5 GW Pharmaceuticals Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Infantile Spasms Therapeutics by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Oral
2.2.3 Injection
2.3 Infantile Spasms Therapeutics by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Hospital
2.3.3 Clinic
2.3.4 Other
2.4 Assumptions and Limitations
3 INFANTILE SPASMS THERAPEUTICS BREAKDOWN DATA BY TYPE
3.1 Global Infantile Spasms Therapeutics Historic Market Size by Type (2019-2024)
3.2 Global Infantile Spasms Therapeutics Forecasted Market Size by Type (2025-2030)
4 INFANTILE SPASMS THERAPEUTICS BREAKDOWN DATA BY APPLICATION
4.1 Global Infantile Spasms Therapeutics Historic Market Size by Application (2019-2024)
4.2 Global Infantile Spasms Therapeutics Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Infantile Spasms Therapeutics Market Perspective (2019-2030)
5.2 Global Infantile Spasms Therapeutics Growth Trends by Region
5.2.1 Global Infantile Spasms Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Infantile Spasms Therapeutics Historic Market Size by Region (2019-2024)
5.2.3 Infantile Spasms Therapeutics Forecasted Market Size by Region (2025-2030)
5.3 Infantile Spasms Therapeutics Market Dynamics
5.3.1 Infantile Spasms Therapeutics Industry Trends
5.3.2 Infantile Spasms Therapeutics Market Drivers
5.3.3 Infantile Spasms Therapeutics Market Challenges
5.3.4 Infantile Spasms Therapeutics Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Infantile Spasms Therapeutics Players by Revenue
6.1.1 Global Top Infantile Spasms Therapeutics Players by Revenue (2019-2024)
6.1.2 Global Infantile Spasms Therapeutics Revenue Market Share by Players (2019-2024)
6.2 Global Infantile Spasms Therapeutics Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Infantile Spasms Therapeutics Head office and Area Served
6.4 Global Infantile Spasms Therapeutics Players, Product Type & Application
6.5 Global Infantile Spasms Therapeutics Players, Date of Enter into This Industry
6.6 Global Infantile Spasms Therapeutics Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Infantile Spasms Therapeutics Market Size (2019-2030)
7.2 North America Infantile Spasms Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Infantile Spasms Therapeutics Market Size by Country (2019-2024)
7.4 North America Infantile Spasms Therapeutics Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Infantile Spasms Therapeutics Market Size (2019-2030)
8.2 Europe Infantile Spasms Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Infantile Spasms Therapeutics Market Size by Country (2019-2024)
8.4 Europe Infantile Spasms Therapeutics Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Infantile Spasms Therapeutics Market Size (2019-2030)
9.2 Asia-Pacific Infantile Spasms Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Infantile Spasms Therapeutics Market Size by Country (2019-2024)
9.4 Asia-Pacific Infantile Spasms Therapeutics Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Infantile Spasms Therapeutics Market Size (2019-2030)
10.2 Latin America Infantile Spasms Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Infantile Spasms Therapeutics Market Size by Country (2019-2024)
10.4 Latin America Infantile Spasms Therapeutics Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Infantile Spasms Therapeutics Market Size (2019-2030)
11.2 Middle East & Africa Infantile Spasms Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Infantile Spasms Therapeutics Market Size by Country (2019-2024)
11.4 Middle East & Africa Infantile Spasms Therapeutics Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 Mallinckrodt
12.1.1 Mallinckrodt Company Information
12.1.2 Mallinckrodt Business Overview
12.1.3 Mallinckrodt Revenue in Infantile Spasms Therapeutics Business (2019-2024)
12.1.4 Mallinckrodt Infantile Spasms Therapeutics Product Portfolio
12.1.5 Mallinckrodt Recent Developments
12.2 H. Lundbeck
12.2.1 H. Lundbeck Company Information
12.2.2 H. Lundbeck Business Overview
12.2.3 H. Lundbeck Revenue in Infantile Spasms Therapeutics Business (2019-2024)
12.2.4 H. Lundbeck Infantile Spasms Therapeutics Product Portfolio
12.2.5 H. Lundbeck Recent Developments
12.3 Insys Therapeutics
12.3.1 Insys Therapeutics Company Information
12.3.2 Insys Therapeutics Business Overview
12.3.3 Insys Therapeutics Revenue in Infantile Spasms Therapeutics Business (2019-2024)
12.3.4 Insys Therapeutics Infantile Spasms Therapeutics Product Portfolio
12.3.5 Insys Therapeutics Recent Developments
12.4 Orphelia Pharma
12.4.1 Orphelia Pharma Company Information
12.4.2 Orphelia Pharma Business Overview
12.4.3 Orphelia Pharma Revenue in Infantile Spasms Therapeutics Business (2019-2024)
12.4.4 Orphelia Pharma Infantile Spasms Therapeutics Product Portfolio
12.4.5 Orphelia Pharma Recent Developments
12.5 Valerion Therapeutics
12.5.1 Valerion Therapeutics Company Information
12.5.2 Valerion Therapeutics Business Overview
12.5.3 Valerion Therapeutics Revenue in Infantile Spasms Therapeutics Business (2019-2024)
12.5.4 Valerion Therapeutics Infantile Spasms Therapeutics Product Portfolio
12.5.5 Valerion Therapeutics Recent Developments
12.6 Catalyst Pharmaceuticals
12.6.1 Catalyst Pharmaceuticals Company Information
12.6.2 Catalyst Pharmaceuticals Business Overview
12.6.3 Catalyst Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2019-2024)
12.6.4 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Product Portfolio
12.6.5 Catalyst Pharmaceuticals Recent Developments
12.7 Anavex Life Sciences
12.7.1 Anavex Life Sciences Company Information
12.7.2 Anavex Life Sciences Business Overview
12.7.3 Anavex Life Sciences Revenue in Infantile Spasms Therapeutics Business (2019-2024)
12.7.4 Anavex Life Sciences Infantile Spasms Therapeutics Product Portfolio
12.7.5 Anavex Life Sciences Recent Developments
12.8 Retrophin
12.8.1 Retrophin Company Information
12.8.2 Retrophin Business Overview
12.8.3 Retrophin Revenue in Infantile Spasms Therapeutics Business (2019-2024)
12.8.4 Retrophin Infantile Spasms Therapeutics Product Portfolio
12.8.5 Retrophin Recent Developments
12.9 GW Pharmaceuticals
12.9.1 GW Pharmaceuticals Company Information
12.9.2 GW Pharmaceuticals Business Overview
12.9.3 GW Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2019-2024)
12.9.4 GW Pharmaceuticals Infantile Spasms Therapeutics Product Portfolio
12.9.5 GW Pharmaceuticals Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
